Venture Life Group (LON:VLG) Hits New 12-Month High – Time to Buy?

Venture Life Group plc (LON:VLG)’s stock price hit a new 52-week high during trading on Monday . The company traded as high as GBX 68 and last traded at GBX 66.85, with a volume of 404085 shares traded. The stock had previously closed at GBX 65.51.

Venture Life Group Trading Up 2.1%

The firm’s 50-day simple moving average is GBX 63.50 and its 200-day simple moving average is GBX 59.46. The firm has a market capitalization of £84.67 million, a PE ratio of -87.96, a price-to-earnings-growth ratio of 5.67 and a beta of 0.30. The company has a quick ratio of 1.48, a current ratio of 2.22 and a debt-to-equity ratio of 28.45.

Insiders Place Their Bets

In related news, insider Jerry Randall sold 387,705 shares of the firm’s stock in a transaction that occurred on Friday, January 9th. The stock was sold at an average price of GBX 66, for a total transaction of £255,885.30. 6.86% of the stock is owned by corporate insiders.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market.

With operations in the UK, The Netherlands and Italy, the Group’s product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women’s intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples.